Drug
Tapinarof
Tapinarof: highest development phase Phase 3, developed by Organon and Co. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Organon and Co
Trials
| Drug | Phase | Indication |
|---|---|---|
| Tapinarof cream, 1% NCT07265479 | Phase 3 | Atopic Dermatitis |
Latest
No recent events.
Follow Tapinarof on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.